Expertise in
4
conditions

Dr. Eric J. Roeland

Oncology
University Andrology Lab LLC
3303 S Bond Ave, 
Portland, OR 
Accepting New Patients
Offers Telehealth
Expertise in
4
conditions
University Andrology Lab LLC
3303 S Bond Ave, 
Portland, OR 

Overview

Eric Roeland is an Oncologist practicing medicine in Portland, Oregon.

Dr. Roeland is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Colorectal Cancer, Pancreatic Cancer, Lynch Syndrome, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 138 peer reviewed articles and participating in 6 clinical trials. Dr. Roeland is currently accepting new patients.

Specialties

Oncology

Licenses

Hospice and Palliative Medicine in CA

Hospital Affiliations

Ohsu Hospital And Clinics

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Regence
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

University Andrology Lab LLC
3303 S Bond Ave, Portland, OR 97239

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Incurable Lung or Non-Colorectal Gastrointestinal Malignancies
Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Incurable Lung or Non-Colorectal Gastrointestinal Malignancies
Enrollment Status: Completed
Publish Date: February 07, 2025
Intervention Type: Other
Study Phase: Phase 3
A Phase 3 Multicenter, Randomized, Double-blind Placebo-controlled Trial Evaluating Crofelemer for the Prophylaxis of Diarrhea in Adult Patients With Solid Tumors Receiving Targeted-cancer Therapies With or Without Standard Chemotherapy
A Phase 3 Multicenter, Randomized, Double-blind Placebo-controlled Trial Evaluating Crofelemer for the Prophylaxis of Diarrhea in Adult Patients With Solid Tumors Receiving Targeted-cancer Therapies With or Without Standard Chemotherapy
Enrollment Status: Completed
Publish Date: July 26, 2024
Intervention Type: Drug
Study Drug: Crofelemer [Mytesi]
Study Phase: Phase 3
A Phase 1b/2 Study of PV-10 Intralesional Injection in Combination With Systemic Immune Checkpoint Inhibition for Treatment of Metastatic Melanoma
A Phase 1b/2 Study of PV-10 Intralesional Injection in Combination With Systemic Immune Checkpoint Inhibition for Treatment of Metastatic Melanoma
Enrollment Status: Unknown
Publish Date: November 21, 2023
Intervention Type: Drug
Study Drugs: PV-10, Pembrolizumab
Study Phase: Phase 1/Phase 2
A Phase II, Randomized, Single Center, Pilot Feasibility Study to Evaluate Naloxegol for Opioid-Induced Constipation in Cancer Patients
A Phase II, Randomized, Single Center, Pilot Feasibility Study to Evaluate Naloxegol for Opioid-Induced Constipation in Cancer Patients
Enrollment Status: Terminated
Publish Date: December 09, 2019
Intervention Type: Drug
Study Phase: Phase 2
Phase II, Open-Label Study to Evaluate Lazanda in Cancer Patients Receiving Palliative Radiation
Phase II, Open-Label Study to Evaluate Lazanda in Cancer Patients Receiving Palliative Radiation
Enrollment Status: Terminated
Publish Date: December 09, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain
A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain
Enrollment Status: Completed
Publish Date: May 15, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 5 Less Clinical Trials

138 Total Publications

Opioid-induced respiratory depression or oversedation risk assessment in hospitalized patients with cancer receiving palliative care.
Opioid-induced respiratory depression or oversedation risk assessment in hospitalized patients with cancer receiving palliative care.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: August 01, 2026
Similar Doctors
Expertise in
24
conditions
Expertise in
24
conditions
Referral may be required

OHSU Knight Cancer Institute South Waterfront

3485 S Bond Ave, 
Portland, OR 
 (0.1 miles away)
503-494-6594
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lara Davis is an Oncologist practicing medicine in Portland, Oregon. Dr. Davis is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Rhabdomyosarcoma Embryonal, and Retroperitoneal Liposarcoma. Dr. Davis is currently accepting new patients.

Expertise in
7
conditions
Expertise in
7
conditions
Referral may be required

OHSU Hospital

3181 SW Sam Jackson Park Rd, 
Portland, OR 
 (0.7 miles away)
503-494-5596
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Brian Druker is an Oncologist practicing medicine in Portland, Oregon. Dr. Druker is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Leukemia, Acute Myeloid Leukemia (AML), and Philadelphia-Negative Chronic Myeloid Leukemia. Dr. Druker is currently accepting new patients.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required
Before you request
4805 Northeast Glisan Street, Suite 11N-1, 
Portland, OR 
 (3.5 miles away)
503-215-5696
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Brendan Curti is an Oncologist practicing medicine in Portland, Oregon. Dr. Curti is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Melanoma, Renal Cell Carcinoma (RCC), Prostate Cancer, and Metastatic Uveal Melanoma. Dr. Curti is currently accepting new patients.

Frequently Asked Questions about Dr. Eric J. Roeland

How do I make an appointment with Dr. Eric J. Roeland?

You can book an appointment with Dr. Eric J. Roeland by calling their office at 503-494-6594. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Eric J. Roeland a top-rated expert for Stomach Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Eric J. Roeland is classified as an Distinguished expert for Stomach Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Eric J. Roeland specialize in?

While Dr. Eric J. Roeland is a Oncology, they have specific expertise in Stomach Cancer, Colorectal Cancer, and Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Eric J. Roeland participate in research or clinical trials?

Yes. Dr. Eric J. Roeland has published 138 articles and abstracts on conditions like Stomach Cancer. You can view a list of Dr. Eric J. Roeland's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Eric J. Roeland accept my insurance?

Dr. Eric J. Roeland accepts most major insurance plans, including Aetna and BridgeSpan. We recommend calling the office directly at 503-494-6594 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Roeland's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile